insights_auto
Why is DAP up ३.९०%?
Dive Deeperchevron_right
DAP:ETR
Danaher Corp
€ २०७.९०
arrow_upward
+३.९०%(+७.८०) 1D
अक्टोबर २१, १७:३५:४९ GMT+२ · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for DAP...
Open
€ १९८.७०
High
€ २०७.९०
Low
€ १८८.८०
Mkt. cap
१.६४ खरब
Avg. vol.
५१९.००
Volume
०.००
52-wk high
€ २०८.३०
52-wk low
€ १३८.२०
No. of employees
५९ हजार
Open
€ १९८.७०
High
€ २०७.९०
Low
€ १८८.८०
Mkt. cap
१.६४ खरब
Avg. vol.
५१९.००
Volume
०.००
52-wk high
€ २०८.३०
52-wk low
€ १३८.२०
No. of employees
५९ हजार
News stories
From web sources and news partners
Yahoo Finance
·
४ घण्टा पहिले
Why Danaher Stock Bounced Higher Today
GuruFocus
·
४ घण्टा पहिले
Danaher Corp (DHR) Reports Q3 2026 Earnings, Highlights Growth S
MarketWatch
·
५ घण्टा पहिले
Danaher Corp. stock outperforms competitors on strong trading day
Investor's Business Daily
·
५ घण्टा पहिले
Medical Giants Bound Higher, Reversing Third-Quarter Worries
Profile
Danaher Corporation is an American healthcare company headquartered in Washington, D.C.. It develops products used for advances in biotechnology, life sciences, and diagnostics. The company operates three divisions: biotechnology, which develops products for the development of therapeutics; life sciences, which develops products to identify causes of disease, new therapies, and to test and manufacture new drugs, vaccines and gene editing technologies; and diagnostics, which develops instruments, consumables, and software and services to diagnose diseases. Danaher was founded in 1984 by brothers Steven Rales and Mitchell Rales; it was named after Danaher Creek in Western Montana, where the brothers came up with the idea for the company while fishing.
The company is ranked 180th on the Fortune 500 and 241st on the Forbes Global 2000. Wikipedia
About Danaher Corp